Covid 19 Updates

Currently, CDC is recommending that moderately to severely immunocompromised people receive an additional dose of the mRNA Covid-19 vaccine at least 28 days after a second dose of Pfizer or Moderna vaccine.  This includes people who have:

  • Been receiving active cancer treatment for tumors or cancers of the blood 
  • Received an organ transplant and are taking medicine to suppress the immune system 
  • Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system 
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome) 
  • Advanced or untreated HIV infection 
  • Active treatment with high-dose corticosteroids (20mg or greater/day) or other drugs that may suppress your immune response

For people who received either Pfizer-BioNTech or Moderna’s COVID-19 vaccine series, a third dose of the same mRNA vaccine should be used.  A person should not receive more than three mRNA vaccine doses.  If the mRNA vaccine product given for the first two doses is not available or is unknown, either mRNA COVID-19 vaccine product may be administered.  Current information from the CDC has not yet determined if a second dose of the Johnson and Johnson vaccine is needed for immunocompromised people.  

CDC does not recommend additional doses or booster shots for any other population at this time. 

Find a COVID-19 Vaccine:

  • Check your local pharmacy’s website to see if vaccination walk-ins or appointments are available 
  • Contact your state or local health department for more information

Updated: 9/07/2021